Meet New Featured Investment Opportunities on NAI500 – Takung Art, AXMIN Inc, Eastwood Bio-Medical

NAI500 is excited to introduce three new companies that have joined our growing online investor platform. Visit their profiles below to learn what investment opportunities they bring.

Takung Art Co Ltd (NYSE AMERICAN:TKAT)
ir.takungart.com

Takung Art Co., Ltd. is a NYSE AMERICAN listed art and culture investment platform based in Hong Kong. The company provides a secure and easy way for art collectors and investors to acquire shared ownership in Asian and other fine art without fear of price manipulation and forgery.

Highlights

• Attractive valuation based on near & long-term growth characteristics
• Earnings leverage on par with e-commerce sector
• The only listed company in artwork-frictional ownership business with few competitors

Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.

AXMIN Inc (TSXV:AXM)
www.axmininc.com

AXMIN Inc. is a TSX Venture listed gold exploration company based in Toronto, Canada. The company is engaged in exploration and development of gold projects situated in Africa.

Highlights

• AXMIN holds a 1.5% net-smelter-return (NSR) royalty in Teranga Gold Corp’s Gora Deposit that amounts to over $3.3 million since the project began production.

Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.

Eastwood Bio-Medical Canada Inc (TSXV:EBM)
www.eleotin.ca

Eastwood Bio-Medical Canada Inc. is a TSX Venture listed company that manufactures, markets and distributes natural health products. The company manufactures and distributes Eleotin products in tea or capsule forms that comprise natural remedies for certain metabolic disorders including diabetes and obesity.

Highlights

• April 17, 2018 – Eastwood Bio-Medical Canada Exercises Right to Purchase Manufacturing Assets of Eastwood Bio-Medical Research Inc.
• May 4, 2018 – Eastwood Bio-medical Canada Inc. Announces Thirty-Five New Products

Click here to visit the company’s NAI500 profile to review their company background, recent press releases, latest presentation and fact sheet, investment highlights, projects and management team.

 

Disclaimer: NAI is being compensated for this article. Materials contained in this article are for information purposes only and is not intended to constitute an offering of securities in any jurisdiction. Nothing on this article should be construed as an offer, solicitation or recommendation to buy or sell products or securities.

Gold Mining Nutraceutical